Trial Details

COMPLETED
Basic Information
Clinical ID c897
Identifier NCT03934216
Trial Title Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: BMS-986165|OTHER: Placebo
Participant Information
Sponsor Bristol-Myers Squibb
City Bristol
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2019-07-01
Primary Completion Date 2021-06-13
Completion Date 2023-04-04